Abiopharma

🔍 Patel Sanj K (Executive)

Company: Kiniksa Pharmaceuticals International, plc (KNSA)

Report Date: 2025-09-01

Detailed Transactions and Holdings:

• Acquired 6,238 shares of Class A Ordinary Share (Direct)
  Date: 2025-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 102,912.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 6,481 shares of Class A Ordinary Share (Direct)
  Date: 2025-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 109,393.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 9,992 shares of Class A Ordinary Share (Direct)
  Date: 2025-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 119,385.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 10,983 shares of Class A Ordinary Share at $33.49 per share (Direct)
  Date: 2025-09-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 108,402.00 | transaction_form_type: 4
• Acquired 6,569 shares of Class A Ordinary Share (Direct)
  Date: 2025-09-02 | Code: M | equity_swap_involved: 0 | shares_owned_after: 114,971.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 3,177 shares of Class A Ordinary Share at $34.28 per share (Direct)
  Date: 2025-09-02 | Code: F | equity_swap_involved: 0 | shares_owned_after: 111,794.00 | transaction_form_type: 4
• Holds 0 shares of Class A Ordinary Share (Direct)
  Date: 2025-09-01 | Code: H | nature_of_ownership: Held by The Marina 2016 Irrevocable Trust, u/d/t June 23, 2016 | shares_owned_after: 109,795.00
• Acquired 34,435 shares of Restricted Share Unit (Derivative)
  Date: 2025-09-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 34,435.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Acquired 137,638 shares of Share Option at $33.49 per share (Derivative)
  Date: 2025-09-01 | Code: A | Expires: 2035-08-31 | equity_swap_involved: 0 | shares_owned_after: 137,638.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 6,238 shares of Restricted Share Unit (Derivative)
  Date: 2025-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 18,712.00 | transaction_form_type: 4 | Footnotes: F1, F4, F4
• Sold 6,481 shares of Restricted Share Unit (Derivative)
  Date: 2025-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 12,962.00 | transaction_form_type: 4 | Footnotes: F1, F5, F5
• Sold 9,992 shares of Restricted Share Unit (Derivative)
  Date: 2025-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 9,991.00 | transaction_form_type: 4 | Footnotes: F1, F6, F6
• Sold 6,569 shares of Restricted Share Unit (Derivative)
  Date: 2025-09-02 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F7, F7

Footnotes:

• F1: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
• F2: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2025.
• F3: The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2025.
• F4: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2024.
• F5: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023.
• F6: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022.
• F7: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021.